Figure 1.
Overall survival in the two groups.
Note: Patients received IP until progression and then EP (group A), or the reverse treatment sequence (group B).
Abbreviations: IP, irinotecan/cisplatin; EP, etoposide/cisplatin.
Overall survival in the two groups.
Note: Patients received IP until progression and then EP (group A), or the reverse treatment sequence (group B).
Abbreviations: IP, irinotecan/cisplatin; EP, etoposide/cisplatin.